185
Views
1
CrossRef citations to date
0
Altmetric
Articles

Comparison of carcinogenic potency across life stages: implications for the assessment of transplacental cancer risk

, , , , &

References

  • Ashouri, K., S. Mohseni, J. Tourtelot, P. Sharma, and P. E. Spiess. 2015. Implications of Von Hippel-Lindau syndrome and renal cell carcinoma. J Kidney Cancer 2:163–73. doi:10.15586/jkcvhl.2015.41.
  • Autrup, H. 1993. Transplacental transfer of genotoxins and transplacental carcinogenesis. Environ Health Perspect 101 (Suppl 2):33–38. doi:10.1289/ehp.93101s233.
  • Balansky, R., G. Ganchev, M. Iltcheva, M. Nikolov, V. E. Steele, and S. De Flora. 2012. Differential carcinogenicity of cigarette smoke in mice exposed either transplacentally, early in life or in adulthood. Int J Cancer 130:1001–10. doi:10.1002/ijc.26103.
  • Barton, H. A., V. J. Cogliano, L. Flowers, L. Valcovic, R. W. Setzer, and T. J. Woodruff. 2005. Assessing susceptibility from early-life exposure to carcinogens. Environ Health Perspect 113:1125–33. doi:10.1289/ehp.7667.
  • Botsivali, M., and S. A. Kyrtopoulos. 2019. Tranplacental exposure to carcinogens and risk to children: Evidence from biomarker studies and the utility of omic profiling. Arch Toxicol 93:833–57. doi:10.1007/s00204-019-02428-3.
  • Brent, R. L. 2014. Carcinogenic risks of prenatal ionizing radiation. Semin Fetal Neonatal Med 19:203–13. doi:10.1016/j.siny.2013.11.009.
  • Bunin, G. R., R. R. Kuijten, C. P. Boesel, J. D. Buckley, and A. T. Meadows. 1994. Maternal diet and risk of astrocytic glioma in children: A report from the Children’s Cancer Group (United States and Canada). Cancer Causes Control 5:177–87.
  • Cheung, O. K. W., and A. S. L. Cheng. 2016. Gender differences in adipocyte metabolism and liver cancer progression. Front Genet 20. doi:10.3389/fgene.2016.00168.
  • Cohn, B. A., M. S. Wolff, P. M. Cirillo, and R. I. Sholtz. 2007. DDT and breast cancer in young women: New data on the significance of age at exposure. Environ Health Perspect 115:1406–14. doi:10.1289/ehp.10260.
  • Cohn, B. A., M. S. Wolff, P. M. Cirillo, R. I. Sholtz, B. A. Cohn, M. La Merrill, N. Y. Krigbaum, G. Yeh, J. S. Park, L. Zimmermann, et al. 2015. DDT exposure in utero and breast cancer. J Clin Endocrinol Metab 100:2865–72. doi:10.1210/jc.2015-1841.
  • Dai, M., S. Y. Euling, and B. Foos. 2018a. A comparative approach to assessing lifestage-dependent susceptibility to estrogenic agent exposures and cancer development. International Conference on Prenatal Programming and Toxicity (PPTOX VI). Tórshavn, Faroe Islands. Poster # P030.
  • Dai, M., S. Y. Euling, and B. Foos. 2018b. Does Early-Life Exposure to Estrogenic Chemicals Warrant an Age Dependent Adjustment Factor in Carcinogen Risk Assessments? Teratology Society 58th Annual Meeting, Clearwater, FL. Poster Abstract P60, published in Birth Defects Research Journal doi:10.1002/bdr2.1355.
  • Diwan, B. A., C. W. Riggs, D. Logsdon, D. C. Haines, O. A. Olivero, J. M. Rice, S. H. Yuspa, M. C. Poirier, and L. M. Anderson. 1999. Multiorgan transplacental and neonatal carcinogenicity of 3ʹ-azido-3ʹ-deoxythymidine in mice. Toxicol Appl Pharmacol 16:82–99. doi:10.1006/taap.1999.8782.
  • Druckrey, H., and C. Landschutz. 1971. Transplacental and neonatal carcinogenesis by ethylnitrosobiuret (enbu) in bd ix-rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 76 (1):45–58.
  • El-Serag, H. B. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–73. doi:10.1053/j.gastro.2011.
  • Freudenthal, R. I., and R. T. Henrich. 2000. Chronic toxicity and carcinogenic potential of tris-(1,3-dichloro-2-propyl) phosphate in Sprague-Dawley rats. Int J Toxicol 19:119–25. doi:10.1080/109158100224926.
  • Ghanayem, B. I. 2006. Inhibition of urethane-induced carcinogenicity in Cyp2E1−/− in comparison to Cyp2E1+/+ mice. Toxicol Sci 95:331–39. doi:10.1093/toxsci/kfl158.
  • Ghissaassi, F. E., H. Bartsch, and A. Barbin. 1998. Metabolic activation of vinyl chloride by rat liver microsomes: Low dose kinetics and involvement of cytochrome P450 2E1. Biochem Pharmacol 55:1445–52. doi:10.1016/s0006-2952(97)00645-x.
  • Ginsberg, G. L. 2003. Assessing cancer risks from short-term exposures in children. Risk Anal 23:19–34.
  • Gold, M. D., A. Blum, and B. N. Ames. 1978. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens. Science 200:785–87. doi:10.1126/science.347576.
  • Health Canada. 2016. Draft screening assessment, certain organic flame retardants substance grouping: TCPP 13674-84-5 and TDCPP 13674-87-8. Appendix F: TDCPP intake estimate from urinary BDCPP biomonitoring reverse dosimetry. Accessed. http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=B4374491-1
  • International Agency for Research on Cancer (IARC) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2010. Volume 94: Ingested nitrates and nitrites, and cyanobacterial peptide toxins. Lyon, France.
  • Klein, M. 1959. Influence of low dose of 2-acetylaminofluorene on liver tumorigenesis in mice. Proc Soc Exp Biol Med 101:637–8.
  • Kommineni, V. R., M. Greenblatt, N. Mihailovich, and S. D. Vesselinovitch. 1970. The significance of perinatal age periods and the dose of urethan on the tumor profile in the mrc rat. Cancer Res 30 (10):2552–5.
  • Maltoni, C., G. Lefemine, A. Ciliberti, G. Cotti, and D. Carretti. 1981. Carcinogenicity bioassays of vinyl chloride monomer: a model of risk assessment on an experimental basis. Environ Health Perspect 41:3–29.
  • Marselos, M., and L. Tomatis. 1992. Diethylstilboestrol: II, pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer 29A:149–55. doi:10.1016/0959-8049(93)90597-9.
  • McKean-Cowdin, R., J. M. Pogoda, W. Lijinsky, E. A. Holly, B. A. Mueller, and S. Preston-Martin. 2003. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol 32:211–17. doi:10.1093/ije/dyg050.
  • Miller, M. S. 2004. Transplacental lung carcinogenesis: Molecular mechanisms and pathogenesis. Toxicol Appl Pharmacol 198:95–110. doi:10.1016/j.taap.2003.07.018.
  • Mohr, U., M. Emura, K. Kamino, J. Steinmann, M. Kohler, and G. Morawietz, et al. 1995. Increased risk of cancer in the descendants of syrian hamsters exposed prenatally to diethylnitrosamine (den). Int J Cancer 63 (1):86–91.
  • Naito, M., Y. Naito, and A. Ito. 1981. Effect of age at treatment on the incidence and location of neurogenic tumors induced in Wistar rats by a single dose of N-ethyl-N-nitrosourea. Gann 72:569–77.
  • Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121–24. doi:10.1126/science.1140485.
  • Nielsen, S., B. A Mueller, S. Preston-Martin, F. M Farin, and E. A Holly, McKean-Cowdin R. Cancer Epidemiol Biomarkers Prev. 2011. Nov;20(11):2413–9. doi:10.1158/1055-9965.EPI-11-0196. Epub 2011 Sep
  • Nomura, T. 1976. Comparison of tumour susceptibility among various organs of foetal. Young and Adult Icr/jcl Mice. Br J Cancer 33 (5):521–34.
  • NRC (National Research Council). 2000. Toxicological risks of selected flame retardant chemicals. Washington DC: National Academy Press. Accessed. https://www.nap.edu/catalog/9841/toxicological-risks-of-selected-flame-retardant-chemicals
  • NRC (National Research Council). 2009. Science and decisions: Advancing risk assessment. Washington DC: National Academy Press.
  • NTP toxicology and carcinogenesis studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). 1999. Natl Toxicol Program Tech Rep Ser.
  • OEHHA (California Office of Environmental Health Hazard Assessment) 2009a. In utero and early life susceptibility to carcinogens. Accessed. https://oehha.ca.gov/media/downloads/crnr/appendixjearly.pdf
  • OEHHA (California Office of Environmental Health Hazard Assessment) 2009b. Technical support document for cancer potency factors, 2009. Accessed: https://oehha.ca.gov/air/crnr/technical-support-document-cancer-potency-factors-2009
  • Preston-Martin, S. 1989. Epidemiological studies of perinatal carcinogenesis. IARC Sci Publ 96:289–314. International Agency for Research on Cancer, Lyon France.
  • Rice, J. M. 1981. Prenatal susceptibility to carcinogenesis by xenobiotic substances including vinyl chloride. Environ Health Perspect 41:179–88. doi:10.1289/ehp.8141179.
  • Romano, M. E., N. L. Hawley, M. Eliot, A. M. Calafat, N. K. Jayatilaka, K. Kelsey, S. McGarvey, M. G. Phipps, D. A. Savitz, E. F. Werner, et al. 2017. Variability and predictors of urinary concentrations of organophosphate flame retardant metabolites among pregnant women in Rhode Island. Environ Health 16:40. doi:10.1186/s12940-017-0247-z.
  • Searles-Nielsen, S., B. A. Mueller, S. Preston-Martin, F. M. Farin, E. A. Holly, and R. McKean-Cowdin. 2011. Childhood brain tumors and maternal cured meat consumption in pregnancy: Differential effect by glutathione S-transferases. Cancer Epidemiol Biomarkers Prev 20:2413–19. doi:10.1158/1055-9965.EPI-11-0196.
  • Titus-Ernstoff, L., E. E. Hatch, R. N. Hoover, J. Palmer, E. R. Greenberg, W. Ricker, R. Kaufman, K. Noller, A. L. Herbst, T. Colton, et al. 2001. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 84:126–33. doi:10.1054/bjoc.2000.1521.
  • Tomatis, L., V. Turusov, D. Guibbert, B. Duperray, C. Malaveille, and H. Pacheco. 1971. Transplacental carcinogenic effect of 3-methylcholanthrene in mice and its quantitation in fetal tissues. J Natl Cancer Inst 47(3):645–51.
  • Toxicology, N. T. P. 2006. Carcinogenesis Studies of AZT (in utero studies) in Swiss Mice. Ntp Tr 522.
  • Troisi, R., E. E. Hatch, L. Titus-Ernstoff, M. Hyer, J. R. Palmer, S. J. Robboy, W. C. Strohsnitter, R. Kaufman, A. L. Herbst, and R. N. Hoover. 2007. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121:356–60. doi:10.1002/ijc.22631.
  • Turusov, V., L. Tomatis, D. Guibberi, B. Duperray, and H. Pacheco. (1973). The effect of prenatal exposure of mice to methyl cholanthrene combined with the neonatal administration of diethylnitrosamine. In: Tomatis, L. And U. Mohr (ED.). International Agency for Research on Cancer Scientific Publication, No 4. Transplacental Carcinogenesis. Proceeding of a Meeting, Hannover, West Germany, Oct 6-7, 1971. XII pp. 84–91. International Agency for Research on Cancer: Lyon, France.
  • U.S. Environmental Protection Agency (U.S. EPA). 2005. Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. March.
  • Vesselinovitch, S. D., K. V. Rao, and N. Mihailovich. 1975. Factors modulating benzidine carcinogenicity bioassay. Cancer Res 35(10):2814–9.
  • Vesselinovitch, S. D., K. V. Rao, and N. Mihailovich. 1979. Transplacental and lactational carcinogenesis by safrole. Cancer Res 39 (11):4378–80.
  • Vesselinovitch, S. D., M. Koka, N. Mihailovich, and K. V. Rao. 1984. Carcinogenicity of diethylnitrosamine in newborn. Infant, and Adult Mice. J Cancer Res Clin Oncol 108 (1):60–5.
  • Waalkes, M. P., J. M. Ward, J. Liu, and B. A. Diwan. 2003. Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 186:7–17. doi:10.1016/S0041-008X(02)00022-4.
  • Zeller, W. J., S. Ivankovic, and J. Zeller. 1978. Induction of malignant tumors in Wistar and Sprague-Dawley rats by single doses of n-butyl-nitrosourea in perinatal and juvenile phases of development. Arch Geschwulstforsch 48:9–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.